Trial
NCT06076837
The Seven Trial: Exploiting the Unfolded Protein Response
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
HonorHealth Research Institute
Collaborators
University of Arizona; Agenus Inc.
Condition
Pancreatic Cancer Metastatic
Intervention
Botensilimab
Why stopped
The study was terminated early per the recommendation of the Data and Safety Monitoring Board (DSMB) after a planned interim analysis met pre-specified criteria for futility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-23